[go: up one dir, main page]

NO995349L - Multivalent vaksinasjonssammensetning med blandet baerer - Google Patents

Multivalent vaksinasjonssammensetning med blandet baerer

Info

Publication number
NO995349L
NO995349L NO995349A NO995349A NO995349L NO 995349 L NO995349 L NO 995349L NO 995349 A NO995349 A NO 995349A NO 995349 A NO995349 A NO 995349A NO 995349 L NO995349 L NO 995349L
Authority
NO
Norway
Prior art keywords
vaccine composition
multivalent vaccine
mixed carrier
polyosides
conjugates
Prior art date
Application number
NO995349A
Other languages
English (en)
Other versions
NO320415B1 (no
NO995349D0 (no
Inventor
Odile Leroy
Original Assignee
Pasteur Merieux Serums Vacc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9507086&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO995349(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pasteur Merieux Serums Vacc filed Critical Pasteur Merieux Serums Vacc
Publication of NO995349L publication Critical patent/NO995349L/no
Publication of NO995349D0 publication Critical patent/NO995349D0/no
Publication of NO320415B1 publication Critical patent/NO320415B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
NO19995349A 1997-05-14 1999-11-02 Multivalent vaksinesammensetning med blandet baerer NO320415B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9706210A FR2763244B1 (fr) 1997-05-14 1997-05-14 Composition vaccinale multivalente a porteur mixte
PCT/FR1998/000966 WO1998051339A1 (fr) 1997-05-14 1998-05-14 Composition vaccinale multivalente a porteur mixte

Publications (3)

Publication Number Publication Date
NO995349L true NO995349L (no) 1999-11-02
NO995349D0 NO995349D0 (no) 1999-11-02
NO320415B1 NO320415B1 (no) 2005-12-05

Family

ID=9507086

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19995349A NO320415B1 (no) 1997-05-14 1999-11-02 Multivalent vaksinesammensetning med blandet baerer

Country Status (20)

Country Link
US (2) US7862823B1 (no)
EP (1) EP0983087B1 (no)
JP (1) JP2001525815A (no)
KR (1) KR100709628B1 (no)
CN (1) CN1154509C (no)
AT (1) ATE279942T1 (no)
AU (1) AU748716B2 (no)
BR (1) BR9808772A (no)
CA (1) CA2289009C (no)
CZ (1) CZ295272B6 (no)
DE (1) DE69827127T2 (no)
ES (1) ES2227840T3 (no)
FR (1) FR2763244B1 (no)
HU (1) HUP0002322A3 (no)
IL (3) IL132669A0 (no)
NO (1) NO320415B1 (no)
NZ (1) NZ500738A (no)
PL (1) PL189653B1 (no)
PT (1) PT983087E (no)
WO (1) WO1998051339A1 (no)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1034792A1 (en) * 1999-03-11 2000-09-13 Pasteur Merieux Serums Et Vaccins Intranasal delivery of pneumococcal polysaccharide vaccines
GB9909077D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Biolog Novel compositions
WO2000056359A2 (en) * 1999-03-19 2000-09-28 Smithkline Beecham Biologicals S.A. Vaccine against streptococcus pneumoniae
FR2806304B1 (fr) * 2000-03-17 2002-05-10 Aventis Pasteur Conjugues polysaccharidiques du pneumocoque a usage vaccinal contre le tetanos et la diphterie
GB0108364D0 (en) * 2001-04-03 2001-05-23 Glaxosmithkline Biolog Sa Vaccine composition
GB0022742D0 (en) * 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
GB0130215D0 (en) * 2001-12-18 2002-02-06 Glaxosmithkline Biolog Sa Vaccine
FR2850106B1 (fr) * 2003-01-17 2005-02-25 Aventis Pasteur Conjugues obtenus par amination reductrice du polysaccharide capsulaire du pneumocoque de serotype 5
PL1740217T3 (pl) 2004-04-30 2012-03-30 Novartis Ag Szczepienie koniugatem meningokokowym
GB0409745D0 (en) 2004-04-30 2004-06-09 Chiron Srl Compositions including unconjugated carrier proteins
GB0500787D0 (en) 2005-01-14 2005-02-23 Chiron Srl Integration of meningococcal conjugate vaccination
GB0419846D0 (en) * 2004-09-07 2004-10-13 Chiron Srl Vaccine adjuvants for saccharides
US7955605B2 (en) 2005-04-08 2011-06-07 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
CN113198012B (zh) 2005-04-08 2024-09-17 惠氏有限责任公司 多价肺炎球菌多糖－蛋白质缀合物组合物
US7709001B2 (en) 2005-04-08 2010-05-04 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
US20070184072A1 (en) 2005-04-08 2007-08-09 Wyeth Multivalent pneumococcal polysaccharide-protein conjugate composition
EP2201961B1 (en) 2005-06-27 2018-01-24 GlaxoSmithKline Biologicals S.A. Immunogenic composition
WO2007026249A2 (en) 2005-09-01 2007-03-08 Novartis Vaccines And Diagnostics Gmbh & Co Kg Multiple vaccination including serogroup c meningococcus
CA2808919C (en) * 2005-12-22 2016-04-19 Glaxosmithkline Biologicals S.A. Streptococcus pneumoniae capsular saccharide vaccine
TW200806315A (en) * 2006-04-26 2008-02-01 Wyeth Corp Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
US8808707B1 (en) 2006-05-08 2014-08-19 Wyeth Llc Pneumococcal dosing regimen
PE20090212A1 (es) 2007-05-02 2009-03-30 Glaxosmithkline Biolog Sa Kit de vacuna para la inmunizacion primaria
AU2008265767B2 (en) * 2007-06-20 2014-11-13 Pfizer Ireland Pharmaceuticals Modified polysaccharides for conjugate vaccines
KR101579947B1 (ko) 2007-06-26 2015-12-28 글락소스미스클라인 바이오로지칼즈 에스.에이. 스트렙토코쿠스 뉴모니애 캡슐 다당류 컨쥬게이트를 포함하는 백신
EP2547357A1 (en) 2010-03-18 2013-01-23 Novartis AG Adjuvanted vaccines for serogroup b meningococcus
WO2012028315A1 (en) 2010-09-02 2012-03-08 Sanofi Pasteur Sa A stabilizer for the preparation of a dry polio injectable vaccine composition
GB201101665D0 (en) 2011-01-31 2011-03-16 Novartis Ag Immunogenic compositions
JP6042455B2 (ja) * 2012-01-30 2016-12-14 セラム インスティチュート オブ インディア プライベイト リミテッド 免疫原性組成物の調製方法
MX2015002483A (es) 2012-10-03 2016-01-08 Glaxosmithkline Biolog Sa Composiciones inmunogenicas.
AR101256A1 (es) 2014-07-21 2016-12-07 Sanofi Pasteur Composición vacunal que comprende ipv y ciclodextrinas
US9107906B1 (en) 2014-10-28 2015-08-18 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
CN105695497B (zh) 2014-11-27 2019-09-24 中国人民解放军军事医学科学院生物工程研究所 一种细菌多糖修饰的重组融合蛋白的制备方法及其应用
MX389480B (es) 2015-06-23 2025-03-20 Biological E Ltd Vacuna conjugada neumococica polivalente.
IL264552B2 (en) 2016-08-05 2023-04-01 Sanofi Pasteur Inc A multivalent pneumococcal protein-polysaccharide conjugate preparation
BR112019001995A2 (pt) * 2016-08-05 2019-05-07 Sanofi Pasteur, Inc. composição de conjugado de polissacarídeo pneumocócico multivalente ? proteína
EP3518965A1 (en) 2016-09-30 2019-08-07 Biological E Limited Multivalent pneumococcal vaccine compositions comprising polysaccharide-protein conjugates
US11951165B2 (en) 2016-12-30 2024-04-09 Vaxcyte, Inc. Conjugated vaccine carrier proteins
US11998599B2 (en) 2016-12-30 2024-06-04 Vaxcyte, Inc. Polypeptide-antigen conjugates with non-natural amino acids
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
US10729763B2 (en) 2017-06-10 2020-08-04 Inventprise, Llc Mixtures of polysaccharide-protein pegylated compounds
KR20240018697A (ko) 2017-06-10 2024-02-13 인벤트프라이즈 인크. 면역원성과 항원항체 결합성이 개선된 2가 또는 다가 접합체 다당류를 가진 다가 접합체 백신
WO2019070994A1 (en) 2017-10-04 2019-04-11 Liffey Biotech Limited SACCHARIDE-POLYPEPTIDE CONJUGATE COMPOSITIONS AND METHODS OF USE
KR20230008923A (ko) * 2018-02-05 2023-01-16 사노피 파스퇴르 인코포레이티드 다가 폐렴구균성 다당류-단백질 접합체 조성물
KR102812816B1 (ko) * 2018-02-05 2025-05-27 사노피 파스퇴르 인코포레이티드 다가 폐렴구균성 다당류-단백질 접합체 조성물
JP2021522213A (ja) 2018-04-18 2021-08-30 エスケー バイオサイエンス カンパニー リミテッド ストレプトコッカス・ニューモニエ莢膜多糖類及びその免疫原性接合体
WO2020010016A1 (en) 2018-07-04 2020-01-09 Sutrovax, Inc. Self-adjuvanted immunogenic conjugates
ES2989087T3 (es) 2018-07-04 2024-11-25 Vaxcyte Inc Mejoras en conjugados inmunogénicos
US20220143166A1 (en) 2018-10-12 2022-05-12 Biological E Limited Multivalent pneumococcal polysaccharide-protein conjugate vaccine
JP7630603B2 (ja) 2020-08-10 2025-02-17 インベントプライズ・インコーポレイテッド 出現血清型２４ｆを含む多価肺炎球菌複合糖質ワクチン
KR20250031146A (ko) 2022-04-11 2025-03-06 사노피 파스퇴르 인크 소듐 시아노보로하이드라이드를 이용한 단백질-당류 접합

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5639022A (en) * 1979-09-05 1981-04-14 Hayashibara Biochem Lab Inc Preparation of vaccine
NZ220932A (en) * 1986-07-03 1990-05-28 Victoria State Composition comprising an antigenic substance, such as lhrh, conjugated to at least two different carriers and method of immunological castration and spaying
CA2059692C (en) * 1991-01-28 2004-11-16 Peter J. Kniskern Pneumoccoccal polysaccharide conjugate vaccine
WO2000056359A2 (en) 1999-03-19 2000-09-28 Smithkline Beecham Biologicals S.A. Vaccine against streptococcus pneumoniae
GB0130215D0 (en) 2001-12-18 2002-02-06 Glaxosmithkline Biolog Sa Vaccine

Also Published As

Publication number Publication date
JP2001525815A (ja) 2001-12-11
PL189653B1 (pl) 2005-09-30
EP0983087A1 (fr) 2000-03-08
DE69827127T2 (de) 2005-03-24
EP0983087B1 (fr) 2004-10-20
HUP0002322A3 (en) 2001-12-28
IL183296A0 (en) 2007-09-20
NO320415B1 (no) 2005-12-05
KR100709628B1 (ko) 2007-04-19
KR20010012477A (ko) 2001-02-15
CA2289009C (fr) 2011-04-26
IL132669A (en) 2010-11-30
HUP0002322A2 (hu) 2000-11-28
CN1255861A (zh) 2000-06-07
ES2227840T3 (es) 2005-04-01
US20110117123A1 (en) 2011-05-19
US8029798B2 (en) 2011-10-04
CZ9904021A3 (en) 2001-06-13
FR2763244A1 (fr) 1998-11-20
CZ295272B6 (cs) 2005-06-15
NO995349D0 (no) 1999-11-02
AU7773098A (en) 1998-12-08
PL336704A1 (en) 2000-07-03
PT983087E (pt) 2005-01-31
US7862823B1 (en) 2011-01-04
ATE279942T1 (de) 2004-11-15
CN1154509C (zh) 2004-06-23
AU748716B2 (en) 2002-06-13
FR2763244B1 (fr) 2003-08-01
CA2289009A1 (fr) 1998-11-19
DE69827127D1 (de) 2004-11-25
NZ500738A (en) 2002-03-28
IL132669A0 (en) 2001-03-19
WO1998051339A1 (fr) 1998-11-19
BR9808772A (pt) 2000-09-05

Similar Documents

Publication Publication Date Title
NO995349D0 (no) Multivalent vaksinasjonssammensetning med blandet baerer
ES2184149T3 (es) Paclitaxeles 6-tio sustituidos.
FR2841900B1 (fr) Nouveaux derives de 1,3-diphenylprop-2-en-1-one substitues, preparation et utilisations
SE9704546D0 (sv) Novel compounds
BR0012243A (pt) Triflúor butenos nematocidas
SE9704545D0 (sv) Novel compounds
SE9704544D0 (sv) Novel compounds
EE201000018A (et) Ravimkompositsioonid, mis p?hinevad antikolinergiliselt toimivatel henditel ja
PE14199A1 (es) Agonistas de 5-ht1f
ATE231872T1 (de) Thiazolopyrimidinderivate
SE9802937D0 (sv) Novel compounds
ID25478A (id) Agonis 5-ht1f
NO995858D0 (no) Ny klasse kationiske nukleinsyre-overföringsmidler
ATE250340T1 (de) 7-methylthiooxomethyl- und 7- methylthiodioxomethyl-paclitaxele
ATE171072T1 (de) Rezeptor-konjugate zum targeting von arzneiwirkstoffen und anderen wirksubstanzen
ECSP003536A (es) Derivados de rufomicina utiles como antibioticos

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees